XML 42 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 29, 2015
Aug. 30, 2014
Operating Activities    
Net earnings $ 26,886 $ 22,892
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 15,502 13,743
Stock-based compensation 2,414 2,582
Deferred income taxes (2,252) 1,620
Excess tax benefits from stock-based compensation (4,699) (2,127)
Gain on disposal of assets (231) (672)
Other, net 549 (89)
Changes in operating assets and liabilities:    
Receivables 19,898 (10,054)
Inventories 1,273 (3,114)
Accounts payable and accrued expenses (12,716) (10,110)
Billings in excess of costs and earnings on uncompleted contracts 3,164 8,107
Refundable and accrued income taxes 13,064 (4,803)
Other, net (754) (1,355)
Net cash provided by (used in) operating activities 62,098 16,620
Investing Activities    
Capital expenditures (19,366) (13,267)
Sales/maturities of restricted investments 0 1,584
Purchases of marketable securities (56,918) (1,366)
Sales/maturities of marketable securities 3,684 6,280
Investments in corporate-owned life insurance policies (892) (427)
Net cash provided by (used in) investing activities (73,492) (7,196)
Financing Activities    
Proceeds from issuance of debt 968 765
Shares withheld for taxes, net of stock issued to employees (3,178) (3,707)
Excess tax benefits from stock-based compensation 4,699 2,127
Repurchase and retirement of common stock 0 (6,894)
Dividends paid (6,431) (5,976)
Net cash provided by (used in) financing activities (3,942) (13,685)
Decrease in cash and cash equivalents (15,336) (4,261)
Effect of exchange rates on cash (659) 444
Cash and cash equivalents at beginning of year 52,185 28,465
Cash and cash equivalents at end of period 36,190  
Noncash Activity    
Capital expenditures in accounts payable $ 1,014 $ 842